Skye Bioscience, Inc.
SKYE· Nasdaq
SKYESkye Bioscience, Inc.
Released May 10, 2024, after the close
10-Q filed May 10, 2024, 40 days after period end · 0001516551-24-000055
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$5.02M | -$5.17M | -$3.04M | -$2.16M |
| EPS Diluted | -$0.18 | -$1.37 | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Mar 31, 2024 · filed May 10, 2024 · 40 d after period end
+12.0% from the close of May 10, 2024 to the close of May 15, 2024, the first after the release.
